Updated:
Palo Alto Investors
Palo Alto Investors runs a physician-led, long-duration equity strategy from Palo Alto. Founded in 1989, the firm embeds MDs in its investment process.
Palo Alto Investors
Palo Alto Investors is an SEC-registered investment adviser in Palo Alto, CA, registered since 2000. The firm manages approximately $696 million in assets. It has 10 employees and 4 investment advisers.
General information
Firm type
Generalist
Year founded
1989
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
Palo Alto, CA, United States
Frequently asked questions
Who runs investment decisions at Palo Alto Investors?
The firm has not publicly named its current investment committee or portfolio managers on its website. The founding team established the physician-led structure in 1989, but individual decision-making roles are not disclosed in available primary materials.
What is Palo Alto Investors' stated investment philosophy?
The firm tells prospective clients it conducts "exhaustive research" to identify long-term investments and states plainly: "We don't rent stocks. We own them." That signals low turnover and a commitment to holding periods that run across market cycles, guided by original, fundamental work.
Is Palo Alto Investors a hedge fund or a long-only manager?
Available materials describe a long-only mandate for high-net-worth and institutional investors. There is no public reference to short-selling, leverage, or hedge-fund structures.
Does Palo Alto Investors manage separate accounts or pooled funds?
The firm's website does not specify its vehicle structures. Given the long-only, fundamental equity strategy and the high-net-worth and institutional client base, it is likely the firm runs both separately managed accounts and commingled funds, but this cannot be confirmed without direct disclosure.
How does the physician-led research model work in practice?
Palo Alto Investors embeds physicians directly within the investment team, a structure established at the firm's 1989 founding. The MDs contribute clinical and scientific expertise to the fundamental research process, with the goal of generating medical and biological insights that give the team an edge in evaluating public companies — particularly in healthcare and life sciences.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: